Your latest news:
Interests in hearing insights on the pharmaceutical packaging supply chain? Access our on demand webinars here and sign up to access our next one!
Your latest news:
Interests in hearing insights on the pharmaceutical packaging supply chain? Access our on demand webinars here and sign up to access our next one!
The CBL-0201DD Phase II study by Caliway Biopharmaceuticals evaluated the first-in-class small-molecule drug for the treatment of Dercum’s disease, a
A new, first-of-its-kind study, published in the online BMJ Evidence-based Medicine, reports that the natural compound found in turmeric may
UCL and Stanford University researchers have made a groundbreaking advancement in cancer treatment by harnessing the power of “click chemistry.”
In order to prevent shortages of antibiotics, the European Health Union is taking proactive measures. The European Commission, in collaboration
Vaxxas, a biotech company specializing in vaccination technology, has opened a state-of-the-art manufacturing facility in Brisbane, Queensland. The 5,500 square
Scientists, Yamin Zhang, Ph.D., and Colin Franz, MD, Ph.D. from Shirley Ryan AbilityLab, and John Rogers, Ph.D. from Northwestern University,
Pfizer’s nasal spray, ZAVZPRET™, which treats migraines, has gained approval from the FDA. It is the first and only calcitonin
Aptar Pharma is launching APF Futurity, its first metal-free, designed-for-recycling multidose nasal spray pump for nasal saline and other over-the-counter pharma
The health insurer’s national formulary considers Amylyx Pharmaceuticals’ Relyvrio to be “experimental, investigational or unproven for any use,” and now
Kiora Pharmaceuticals, specialises in ophthalmology, developing treatment therapies for eye diseases. They have received approval for their new drug, KIO-101,
Chester Medical has ploughed just under £500,000 CAPEX investment as it continues to grow. With Jenny Dixon who joined Chester
Aptar Pharma, is a pharmaceutical leader in the manufacturing and development of drug delivery systems and solutions. They have launched
